Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

If you believe the pipeline is currently worth $100 million or more, you can rest easy that the CEO has every incentive to do a deal.

If you believe that two phase 3 ready indications in Brilacidin along with numerous additional preclinical and clinical indications are a scam or worth less than $25 million, then sell.

Everyone has to value the pipeline themselves and make the appropriate decision. If its not a sham, they arent going it alone. No incentive to.